NCT07813637
- Conditions
- Castration-Resistant Prostate Cancer (CRPC), Genital Diseases, Genital Diseases, Male, +11 more
- Locations
-
- Sarah Cannon Research Institute Nashville, Tennessee, United States
Clinical trial condition
Castration-Resistant Prostate Cancer (CRPC)
Explore clinical trials studying Castration-Resistant Prostate Cancer (CRPC). Study availability and eligibility vary by location and protocol.
8 public trials
4 recruiting studies
Castration-Resistant Prostate Cancer (CRPC) trial results
NCT07745361
- Conditions
- Adenocarcinoma, Carcinoma, Castration-Resistant Prostate Cancer (CRPC), +15 more
- Locations
-
- START Los Angeles Los Angeles, California, United States
- Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
- Rocky Mountain Cancer Center Colorado Springs, Colorado, United States
- Kansas University Cancer Center Kansas City, Kansas, United States
NCT07540572
- Conditions
- Brain Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +30 more
- Locations
-
- Florida Clinical Trials Group Plantation, Florida, United States
- START Astera, LLC East Brunswick, New Jersey, United States
- START New York Long Island, LLC Lake Success, New York, United States
- NEXT Texas LLC - Austin Austin, Texas, United States
NCT07189871
- Conditions
- Adnexal Diseases, Breast Diseases, Breast Neoplasms, +60 more
- Locations
-
- Dothan Hematology & Oncology Dothan, Alabama, United States
- BAMF Health Grand Rapids, Michigan, United States
- Nebraska Cancer Specialists Omaha, Nebraska, United States
- XCancer Omaha, Nebraska, United States
Not yet recruiting
Safety, Tolerability, and Efficacy of CP-PCA07 in Combination With Enzalutamide in Patients With Castration-Resistant Prostate Cancer
NCT07683013
- Conditions
- Castration-Resistant Prostate Cancer (CRPC)
- Locations
-
- Seoul National University Hospital Seoul, South Korea
Enrolling by invitation
A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer
NCT07240857
- Conditions
- Castration-Resistant Prostate Cancer (CRPC)
- Locations
-
- The First Affiliated Hospital of Zhejiang University Hangzhou, Zhejiang, China
Enrolling by invitation
YS247 (Neoantigen-Pulsed DC Vaccine) for Metastatic Prostate Cancer
NCT07583160
- Conditions
- Castration-Resistant Prostate Cancer (CRPC), Genital Diseases, Genital Diseases, Male, +10 more
- Locations
-
- Shanghai Changhai Hospital Shanghai, Shanghai Municipality, China
NCT01534052
- Conditions
- Castration-Resistant Prostate Cancer (CRPC), Genital Diseases, Genital Diseases, Male, +8 more
- Locations
-
- Site US107 Aurora, Colorado, United States
- Site US104 Chicago, Illinois, United States
- Site US105 Pittsburgh, Pennsylvania, United States
- Site US106 San Antonio, Texas, United States